Latest Regulatory News

Global Masters Fund Limited reports steady convertible note activity and a robust loan-to-value ratio of 9.36% for the December 2025 quarter, underscoring its solid financial footing.

Flagship Investments Limited has confirmed stable financial metrics for its convertible notes in the December 2025 quarter, maintaining a conservative loan-to-value ratio and full compliance with regulatory requirements.

ECP Emerging Growth Limited has reported steady financial health for its convertible notes, maintaining a 28.03% loan-to-value ratio and full compliance with regulatory requirements for the quarter ending December 2025.

Eastern Metals Limited has responded to ASX concerns over delayed disclosure of director interest changes, attributing the lapse to end-of-year administrative challenges while affirming its compliance framework remains robust.

Findi Limited has landed a significant pre-IPO investment from Nova Global Opportunities Fund PCC, setting the stage for its Indian subsidiary’s planned listing on the Bombay Stock Exchange by FY27. This deal supports a Findi share price target between $5.58 and $6.69.

Saunders International has landed a $16.4 million contract to refurbish a fuel storage tank at Ampol’s Lytton Refinery, reinforcing its role in Australia’s energy infrastructure upgrades.

ReNerve Limited has secured market approval for its NervAlign® Nerve Cuff in Malaysia, marking a key milestone in its Asia-Pacific expansion strategy. This approval follows earlier clearances in Hong Kong and Thailand, positioning the company to tap into a growing regional nerve repair market.

Southern Cross Gold Consolidated Ltd. has achieved a pivotal regulatory milestone enabling underground exploration at its Sunday Creek project, backed by strong drilling results and a robust cash position of $130.4 million.

BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for several Australian-domiciled iShares ETFs for the December 2025 distribution period, providing key details for investors opting into reinvestment.

Metgasco shareholders have approved the sale of their 25% stake in the Southern Flank joint ventures to Vintage Energy, marking a key milestone in Vintage’s strategic expansion. The deal still awaits final conditions before completion.

Neuren Pharmaceuticals’ partner Acadia projects DAYBUE sales to reach around US$700 million by 2028, driven by US market expansion and international approvals. The launch of a new formulation and ongoing clinical trials in Japan underpin this optimistic outlook.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.